SCHIAVON, ODDONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.005
AS - Asia 3.846
EU - Europa 1.659
AF - Africa 639
SA - Sud America 573
OC - Oceania 72
Continente sconosciuto - Info sul continente non disponibili 34
Totale 14.828
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.683
SG - Singapore 1.158
CN - Cina 694
VN - Vietnam 643
HK - Hong Kong 412
BR - Brasile 322
IT - Italia 238
FR - Francia 189
FI - Finlandia 187
DE - Germania 166
UA - Ucraina 103
IN - India 100
BD - Bangladesh 89
PL - Polonia 81
GB - Regno Unito 69
SE - Svezia 69
IQ - Iraq 60
RU - Federazione Russa 59
TR - Turchia 50
NL - Olanda 48
AR - Argentina 46
CO - Colombia 43
PK - Pakistan 43
PH - Filippine 39
CA - Canada 35
ID - Indonesia 35
ZA - Sudafrica 34
MY - Malesia 33
UZ - Uzbekistan 33
SA - Arabia Saudita 32
JP - Giappone 31
MA - Marocco 31
TN - Tunisia 29
IE - Irlanda 28
BY - Bielorussia 26
JO - Giordania 26
ET - Etiopia 25
MX - Messico 25
PT - Portogallo 25
PY - Paraguay 25
BB - Barbados 24
ES - Italia 24
AE - Emirati Arabi Uniti 23
BE - Belgio 23
EG - Egitto 23
DZ - Algeria 22
EC - Ecuador 22
IL - Israele 22
BO - Bolivia 21
GF - Guiana Francese 21
AZ - Azerbaigian 20
CL - Cile 20
CW - ???statistics.table.value.countryCode.CW??? 20
MR - Mauritania 20
NI - Nicaragua 20
TT - Trinidad e Tobago 20
BZ - Belize 19
HN - Honduras 19
KZ - Kazakistan 19
VE - Venezuela 19
AF - Afghanistan, Repubblica islamica di 18
BF - Burkina Faso 18
CR - Costa Rica 18
DJ - Gibuti 18
DO - Repubblica Dominicana 18
HU - Ungheria 18
IR - Iran 18
LY - Libia 18
ME - Montenegro 18
PS - Palestinian Territory 18
RO - Romania 18
TJ - Tagikistan 18
UG - Uganda 18
UY - Uruguay 18
BW - Botswana 17
EE - Estonia 17
KG - Kirghizistan 17
LA - Repubblica Popolare Democratica del Laos 17
MG - Madagascar 17
MN - Mongolia 17
RS - Serbia 17
SI - Slovenia 17
YT - Mayotte 17
AD - Andorra 16
AL - Albania 16
BA - Bosnia-Erzegovina 16
BG - Bulgaria 16
CH - Svizzera 16
GA - Gabon 16
KE - Kenya 16
KR - Corea 16
LB - Libano 16
PA - Panama 16
PE - Perù 16
CM - Camerun 15
GM - Gambi 15
GN - Guinea 15
JM - Giamaica 15
MD - Moldavia 15
NC - Nuova Caledonia 15
Totale 14.156
Salva come PNG Salva come JPEG
Città #
San Jose 800
Fairfield 756
Ashburn 729
Singapore 706
Woodbridge 651
Houston 495
Chandler 486
Ann Arbor 478
Jacksonville 462
Hong Kong 379
Seattle 302
Wilmington 295
Santa Clara 261
Cambridge 232
Ho Chi Minh City 181
Beijing 166
Hanoi 139
Princeton 133
Boardman 128
San Diego 92
Los Angeles 88
Lauterbourg 85
Helsinki 82
Nanjing 71
Dong Ket 69
Medford 67
Bytom 55
Roxbury 52
New York 47
Padova 39
Orem 38
Munich 34
Da Nang 33
Tashkent 29
Buffalo 28
Chicago 27
Haiphong 27
Amman 25
Baghdad 25
Des Moines 25
Nanchang 24
Verona 24
Dublin 23
Changsha 22
Bridgetown 21
Norwalk 21
Baku 19
Managua 19
Nouakchott 19
Hebei 18
Kampala 18
Lahore 18
Chennai 17
Djibouti 17
Dushanbe 17
Guangzhou 17
Montevideo 17
Podgorica 17
Shanghai 17
Tianjin 17
Ulan Bator 17
Amsterdam 16
Andorra la Vella 16
Dhaka 16
Panama City 16
Rio de Janeiro 16
São Paulo 16
Tokyo 16
Addis Ababa 15
Antananarivo 15
Asunción 15
Rome 15
Tallinn 15
Vientiane 15
Willemstad 15
Cayenne 14
Harare 14
Johannesburg 14
Libreville 14
Medellín 14
Minsk 14
Montreal 14
Noumea 14
San José 14
Tripoli 14
Tunis 14
Belo Horizonte 13
Bishkek 13
Brooklyn 13
Dar es Salaam 13
Kigali 13
Luanda 13
Papeete 13
San Francisco 13
Shenyang 13
Belize City 12
Cairo 12
Conakry 12
Cotonou 12
Dakar 12
Totale 9.764
Salva come PNG Salva come JPEG
Nome #
Hyaluronic acid as a protein polymeric carrier: An overview and a report on human growth hormone 306
A Non-Covalent Antibody Complex for the Delivery of anti-cancer drugs 305
Chemical and Enzymatic Site Specific PEGylation of hGH: The Stability and in vivo Activity of PEG-N-Terminal-hGH and PEG-Gln141-hGH Conjugates 291
A Biodegradable Polymeric Carrier Based on PEG for Drug Delivery 276
Drug and protein delivery by polymer conjugation 274
Middle-term expansion of hematopoietic cord blood cells with new human stromal cell line feeder-layers and different cytokine cocktails 273
Preservation of Thrombolytic Activity of Urokinase Modified with Monomethoxypoly(ethylene glycol 245
Covalent immobilisation of transglutaminase: stability and applications in protein PEGylation 241
Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy. 231
Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation 224
A branched monomethoxypoly(ethylene glycol) for protein modification 222
Accurate evaluation method of the polymer content in Monomethoxy(polyethylene glycol) modified proteins based on Amino acid analysis 219
Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly(ethylene glycol) and poly(N-acryloylmorpholine) 219
Biopharmaceutical properties of uricase conjugated to neutral and amphiphilic polymers 212
Bassi polimeri dell'N-acriloil morfolina monofunzionalizzati ad un estremo per la preparazione di coniugati con enzimi, polipeptidi e farmaci 207
An improved procedure for the synthesis of branched polyethylene glycols (PEGs) with the reporter dipeptide Met-betaAla for protein conjugation. 207
Pegylated enzyme entrapped in poly(vinyl alcohol) hydrogel for biocatalytic application 197
Preparation and characterization of novel poly(ethylene glycol) paclitaxel derivatives 195
Covalent modification of mushroom tyrosinase with different amphiphic polymers for pharmaceutical and biocatalysis applications 194
Protective effect of superoxide dismutase and polyethylene glycol-linked superoxide dismutase against renal warm ischemia/reperfusion injury 193
Relevance of folic acid/polymer ratio in targeted PEG-epirubicin conjugates 190
PHEA-Graft-Polymethacrylate Supramolecular Aggregates for Protein Oral Delivery 187
PEG-Ara-C conjugates for controlled release 187
PEG-epirubicin conjugates with high drug loading 185
Physico-Chemical and Biological Properties of Monofunctional Hydroxy Teriminating Poly(N-Vinylpyrrolidone) Conjugated Superoxide Dismutase 179
PEG-doxorubicin conjugates: Influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity 178
Preparation, physico-chemical and pharmacokinetic characterization of monomethoxypoly(ethylene glycol)-derivatized superoxide dismutase 176
A Method to maintain the activity in polyethylene glycol-modified proteolytic enzymes 174
Antitumoral activity of peg-gemcitabine prodrugs targeted by folic acid 174
Branched and linear poly(ethylene glycol): Influence of the polymer structure on enzymological, pharmacokinetic, and immunological properties of protein conjugates 173
Polysialic acid as a drug carrier: evaluation of a new polysialic acid–epirubicin conjugate and its comparison against established drug carriers 173
Modification of physico-chemical and biopharmaceutical properties of superoxide dismutase by conjugation to the co-polymer of divinyl ether and maleic anhydride 168
Improvement of pharmacokinetic, immunological and stability properties of asparaginase by conjugation to linear and branched monomethoxy poly(ethylene glycol) 166
Drug-Protein Interaction: 8-Methoxy Psoralen as Photosensitizer of Enzymes and Amino Acids 164
End functionalized PVP as new oligomer for enzyme modification 163
A new method for high selective TGase-mediated PEGylation of salmon calcitonin and human growth hormone 162
Biologically active conjugates having a detector reporter moiety and method of identificationof said derivative 160
New synthetic polymers for enzyme and liposome modification 158
pH-responsive liposomes for enhanced drug delivery to the tumour. 157
New active poly(ethylene glycol) derivative for amino coupling 155
Synthesis and molecular weight characterization of low molecular weight end-functionalized poly(4-acryloylmorpholine) 154
Anti-inflammatory and pharmacokinetic properties of superoxide dismutase derivatized with polyethylene glycol via active esters. 154
Peg-doxorubicin conjugates with high loading 153
Controlled Drug Delivery Microspheres for Osteogenic Differentiation 149
Distribution of catalase, ribonuclease and superoxide dismutase modified by monomethoxy (polyethylene glycol) into rat central lymph and lymphatic nodes 147
Folic acid targeted PEG-epirubicin conjugate with lysosomotropic drug release 144
Solution-phase site-specific preparation of GRF-PEG conjugates 142
Polymers of N-acryloylmorpholine activated at one end and conjugated with bioactive materials and surfaces 139
Molecular bases of biological properties of angiogenin: application in tissue engineering. 138
Influence of PEGylation on the release of low and high molecular-weight proteins from PVA matrices 138
Enzyme modification by MPEG with an amino acid or peptide as spacer arms 138
Molecular bases of angiogenin: Applications in tissue engineering 137
hGH-PEG-betaAla coniugate releasing the native protein: pharmacokinetic evaluation in monkeys and activity investigation in hypophysectomized rats. 136
Extensive crosslinking between subunits of oligomeric proteins induced by furocoumarins plus UV-A irradiation. 136
Poly(ethylene glycol)-Poly(ester-carbonate) Blok Copolymers Carrying PEG-Peptidyl-Doxorubicin Pendant Side Chain: Synthesis and Evaluation as Anticancer Conjugates 135
New chain terminated N-vinyl lactam polymer and grafts copolymers and methods for making same 134
New active poly(ethylene glycol) derivative for amino coupling 134
Poly(N-acryloylmorpholine) can be used in alternative to poly(ethylene glycol) for protein modification. 132
Polyethylene glycol (PEG)-dendron phospholipids as innovative pharmaceutical products to make super stealth liposomes for anticancer therapy 132
New PEG's for peptides and protein modification, suitable for the identification of the peghilation site 131
Active poly(ethylene glycol) carbamate for protein modification 131
Surface modification of proteins. Activation of monomethoxy-polyethylene glycols by phenylchloroformates and modification of ribonuclease and superoxide dismutase. 131
Dendritic PEG-epirubicin conjugates with high loading 130
A high molecular weight form of human urinary urokinase. 129
Relevance of folic acid/polymer ratio in targeted epirubicin polymer conjugates. 127
Bassi polimeri dell' N-vinilpirrolidone monofunzionalizzati ad un estremo per la preparazione di coniugati con enzimi, polipeptidi, farmaci 125
Controlled drug delivery microspheres for osteogenic differentiation 125
Poly(N-acryloylmorpholine) as a new soluble support for the liquid-phase synthesis of oligonucleotides. 123
Enzymatically active subunits of Bacillus stearothermophilus enolase bound to Sepharose. 122
Folic acid targeted PEG-epirubicin: the influence of folic acid/PEG ratio on coniugate cytotoxicity. 118
Polymeric prodrug of gemcitabine 116
Molecular relationship of different activities of angiogenin: application in tissue engineering. 115
Studies on natural and synthetic high molecular weight forms of urokinase 114
Dendritic PEG liposomes for the delivery of anticancer drugs 114
Drug protein interaction: inhibition of glutamate dehydrogenase by psycoactive butyrophenones. 113
Photoinactivation of enzymes by linear and angular furocoumarins. 113
Multi-armed monofunctional and hydrolitically stable derivatives of poly (ethylene glycol) and related polymers for modification of surfaces and molecules 112
The modification of ribonuclease-A by near ultraviolet irradiation in the presence of psoralen. 112
PEG superoxide dismutase derivatives: anti-inflammatory activity in carrageenan pelurisy in rats. 111
Multibranched PEG to improve the conjugate loading of Ara-C 111
The effect of psoralens and angelicins on proteins in the presence of UV-A irradiation. 110
Synthesis and Biological Properties of Folate-PEG-Gemcitabine 108
Tumor targeting of doxorubicin bound to peg of different size and shape. 27th International Symposium on controlled release of bioactive materials. 106
Metodo per mantenere l'attività di enzimi proteolitici modificati con polietilenglicole 105
Poly(N-Acryloylmorpholine) can be used in alternative to poly(ethylene glycol) for protein modification 104
Drug-protein interaction: plasma protein binding of furocoumarins. 100
Folate-targeted PEG-Gemcitabine 100
polymeric conjugate of phospholipids 98
Synthesis and Pharmacokinetic studies of dendritic PEG-epirubicin 97
General stability of thermophilic enzymes: studies on 6-phosphogluconate dehydrogenase from Bacillus stearothermophilus and yeast. 93
The binding of 8-methoxypsoralen by human serum albumin. 92
Evaluation of monomethoxypolyethyleneglycol derivatized superoxide dismutase in blood and evidence for its binding to blood cells. 86
Epirubicine-PEG-folate conjugates: the effects of folic acid and folic acid / polymer ratio on conjugates cytotoxicity and cellular uptake. 80
The study of the furocoumarin-serum albumin complex by difference spectrophotometry and gel exclusion. 77
Synthesis and biological studies of PEG-epirubicin conjugates 74
Drug protein interaction: displacement of albumin bound 8-methoxypsoralen by drugs. 71
Totale 14.856
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.210
article - articoli 29.332
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 3.588
selected - selezionate 0
volume - volumi 697
Totale 74.827
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021235 0 0 0 0 0 0 0 0 0 0 126 109
2021/20221.000 7 167 136 64 39 28 46 110 49 9 126 219
2022/2023942 210 95 7 82 166 129 2 70 106 3 57 15
2023/2024324 16 71 39 28 14 5 24 8 15 18 47 39
2024/20251.700 0 73 94 57 408 44 55 133 111 60 289 376
2025/20266.688 196 595 974 1.100 573 243 918 644 700 440 305 0
Totale 14.856